COLLECTIVE GROWTH CORPORATION ANNOUNCES CLOSING OF $150 MILLION INITIAL PUBLIC OFFERING

Rhea-AI Summary

Collective Growth Corporation (Nasdaq: CGROU) has successfully completed its initial public offering (IPO), raising $150 million by selling 15 million units at $10.00 each. Each unit includes one share of Class A common stock and a half warrant, with the warrants allowing the purchase of additional shares at $11.50.

The proceeds from the IPO will be placed in trust, with the units starting to trade on May 1, 2020. Collective Growth aims to merge with businesses in the federally permissible cannabinoid industry.

Positive

• Successfully raised $150 million through the initial public offering.
• Units began trading on Nasdaq, potentially increasing visibility and liquidity.

Negative

• The potential dilution of shares due to additional warrants affecting existing shareholders.

Austin, TX, May 05, 2020 (GLOBE NEWSWIRE) --  Collective Growth Corporation (Nasdaq: CGROU) (the “Company”) announced today that it closed its initial public offering of 15,000,000 units at $10.00 per unit. The offering was priced at $10.00 per unit, resulting in gross proceeds of $150,000,000.

The Company’s units began trading on the Nasdaq Capital Market under the symbol “CGROU” on May 1, 2020.  Each unit consists of one share of the Company’s Class A common stock (“Class A Common Stock”) and one-half of one redeemable warrant (“Warrant”) with each whole Warrant entitling the holder to purchase one share of Class A Common Stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A Common Stock and Warrants are expected to be traded on Nasdaq under the symbols “CGRO”, and “CGROW”, respectively.

Cantor Fitzgerald & Co. acted as book-running manager of the offering.

Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units and warrants, $150,000,000 (or $10.00 per unit sold in the public offering) was placed in trust. An audited balance sheet of the Company as of May 5, 2020 reflecting receipt of the proceeds upon consummation of the initial public offering and the private placement will be included as an exhibit to a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission (“SEC”).

Graubard Miller acted as counsel to the Company and Ellenoff Grossman & Schole LLP acted as counsel to the underwriters.

The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 5th Floor New York, New York 10022; Email: prospectus@cantor.com. Copies of the prospectus can also be accessed through the SEC’s website at www.sec.gov.

A registration statement relating to these securities has been declared effective by the SEC on April 30, 2020.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Collective Growth Corporation

Collective Growth Corporation is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although the Company initially intends to focus on target businesses operating in the Federally permissible cannabinoid industry which are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate. In particular, the Company will not invest in or consummate a business combination with a target business that the Company determines has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements, including those set forth in the risk factors section of the prospectus used in connection with the Company’s initial public offering.  No assurance can be given that the net proceeds of the offering will be used as indicated. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based, except as required by law.

Contact:

Wilson Kello

info@collectivegrowthcorp.com 

FAQ

What was the total amount raised in Collective Growth's IPO on May 5, 2020?

Collective Growth Corporation raised a total of $150 million in its IPO.

When did Collective Growth's units start trading on Nasdaq?

The units of Collective Growth Corporation began trading on May 1, 2020.

What does each unit of Collective Growth's IPO consist of?

Each unit consists of one share of Class A common stock and one-half of one redeemable warrant.

What is the exercise price of the warrants for Collective Growth's stock?

Each whole warrant allows the purchase of one share of Class A common stock at a price of $11.50.

What industry does Collective Growth Corporation intend to focus on for mergers and acquisitions?

Collective Growth Corporation plans to focus on the federally permissible cannabinoid industry.